Literature DB >> 23426442

18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.

Nikos Kastrinidis1, Felix P Kuhn, Thomas F Hany, Nader Ahmad, Gerhard F Huber, Stephan K Haerle.   

Abstract

OBJECTIVES/HYPOTHESIS: The aim was to compare the value of 18-Fluoro-Deoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) regarding contralateral lymph node (LN) metastasis in the neck. STUDY
DESIGN: Retrospective analysis of 61 patients staged by 18F-FDG-PET/CT.
METHODS: Cytology/histology served as a reference standard. Further, metabolic midline invasion (MI) of the primary tumor and the presence of bilateral LN metastases were assessed.
RESULTS: A true positive rate in the ipsilateral neck of 80% versus 65% in the contralateral neck was found (P = 0.067). Median-standardized uptake value (SUV)-max for suspicious LN ipsilaterally was 7.6 versus 5.8 contralaterally (P = 0.038). There was no positive correlation between metabolic MI and bilateral metastasis (P = 0.82).
CONCLUSIONS: The rate of true positive detected LN by 18F-FDG-PET/CT is less on the contralateral neck side; therefore, all suspicious LNs should be verified by cytology. A high SUV in the contralateral neck suggests metastatic disease regardless of nodal size. Metabolic MI needs to be addressed carefully as it was not predictive for bilateral LN involvement. LEVEL OF EVIDENCE: 4.
Copyright © 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426442     DOI: 10.1002/lary.23944

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Tomonori Kanda; Naoki Otsuki; Ken-Ichi Nibu; Ryohei Sasaki; Tomoo Itoh; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-12-15       Impact factor: 2.374

Review 2.  PET imaging biomarkers in head and neck cancer.

Authors:  Sarah Differding; François-Xavier Hanin; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

Review 3.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

4.  18F-FDG PET/CT scan confirmed by pathology findings in a singular case of squamous cell carcinoma of the epiglottis.

Authors:  G M Lima; A Matti; L Burgio; C Nanni; P Castellucci; S Fanti
Journal:  Eur J Hybrid Imaging       Date:  2017-11-15

5.  Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.

Authors:  Thomas M Stadler; Martin W Hüllner; Martina A Broglie; Grégoire B Morand
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.